Making method of mammary gland disease prevention and treatment fabric
A breast disease and fabric technology, which is applied in textiles, papermaking, and fiber processing, can solve problems such as discomfort, poor air permeability, and skin allergies, and achieve the effects of ensuring aesthetics, improving slow-release performance, and ensuring comfort
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] The described receiving solution containing microcapsules adopts the following specific preparation steps:
[0063] a) Prepare a polyurethane wall material solution with a mass fraction of 3.8% by polyurethane wall material and dimethylformamide (DMF) solvent;
[0064] b) The main drug tamoxifen drug transdermal agent propylene glycol core material is prepared into solutions with a mass fraction of 3% and 45% respectively, and then the selected main drug tamoxifen, drug transdermal agent propylene glycol core material and polyurethane The wall material solution is subjected to high-voltage electric spraying through the three-way pipe fittings according to the method described in the above step 1.3), and 20Kv DC high-voltage static electricity is applied;
[0065] c) Use a micro-injection pump to spray from the needle of the dispensing needle. The flow rate of the external liquid is 1.5mL / h, and the flow rate of the two internal liquids is 0.75mL / h. It is received by dis...
Embodiment 2
[0070] The described receiving solution containing microcapsules adopts the following specific preparation steps:
[0071] a) Prepare a polyurethane wall material solution with a mass fraction of 3.3% by polyurethane wall material and dimethylformamide (DMF) solvent;
[0072] b) Prepare the main drug tamoxifen drug transdermal agent propylene glycol core material into solutions with a mass fraction of 1% and 10% respectively, and then use the high-voltage electrospray method to mix the selected main drug tamoxifen, drug transdermal agent propylene glycol core material and polyurethane The wall material solution is subjected to high-voltage electric spraying through the three-way pipe fittings according to the method described in the above step 1.3), and 20Kv DC high-voltage static electricity is applied;
[0073] c) Use a micro-injection pump to spray from the needle of the dispensing needle. The flow rate of the external liquid is 0.5mL / h, and the flow rate of the two interna...
Embodiment 3
[0078] The described receiving solution containing microcapsules adopts the following specific preparation steps:
[0079] a) Prepare a polyurethane wall material solution with a mass fraction of 3.5% of the polyurethane wall material and dimethylformamide (DMF) solvent;
[0080] b) The main drug tamoxifen drug transdermal agent propylene glycol core material is prepared into solutions with mass fractions of 2% and 25% respectively, and then the selected main drug tamoxifen, drug transdermal agent propylene glycol core material and polyurethane The wall material solution is subjected to high-voltage electric spraying through the three-way pipe fittings according to the method described in the above step 1.3), and 20Kv DC high-voltage static electricity is applied;
[0081] c) Use a micro-injection pump to spray from the needle of the dispensing needle. The flow rate of the external liquid is 1.2mL / h, and the flow rate of the two internal liquids is 0.6mL / h. It is received by d...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com